Used as an intermediate in pharmaceutical synthesis, particularly in the development of bioactive molecules and drug candidates targeting central nervous system disorders. Its structure supports the construction of complex piperazine-based compounds with potential antipsychotic, antidepressant, or cognitive-enhancing activity. The azetidine and piperazine moieties offer favorable pharmacokinetic properties and binding affinity to various receptors, making it valuable in medicinal chemistry for optimizing lead compounds. Commonly employed in research settings for structure-activity relationship (SAR) studies and the design of novel therapeutics.